Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-25 @ 9:29 PM
Study NCT ID:
NCT03337451
Status:
COMPLETED
Last Update Posted:
2019-01-28
First Post:
2017-10-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome
Sponsor:
Opsona Therapeutics Ltd.